Previous Article | Next Article 
Journal of Virology, February 1999, p. 920-929, Vol. 73, No. 2
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
A Herpes Simplex Virus Type 1 Latency-Associated
Transcript Mutant with Increased Virulence and Reduced
Spontaneous Reactivation
Guey-Chuen
Perng,1
Susan M.
Slanina,1
Ada
Yukht,1
Barbara S.
Drolet,1
William
Keleher Jr.,1
Homayon
Ghiasi,1,2
Anthony B.
Nesburn,1,2 and
Steven L.
Wechsler1,2,*
Ophthalmology Research Laboratories,
Cedars-Sinai Medical Center Burns & Allen Research Institute, Los
Angeles, California 90048,1 and
Department of Ophthalmology, UCLA School of Medicine, Los
Angeles, California 900242
Received 18 September 1998/Accepted 22 October 1998
 |
ABSTRACT |
The herpes simplex virus type 1 (HSV-1) latency-associated
transcript (LAT) gene is essential for efficient spontaneous
reactivation of HSV-1 from latency. We previously reported that
insertion of the LAT promoter and just the first 1.5 kb of the 8.3-kb
LAT gene into an ectopic location in the virus restored wild-type
spontaneous reactivation to a LAT null mutant. This mutant, LAT3.3A
(previously designated LAT1.5a), thus showed that the expression of
just the first 1.5 kb of LAT is sufficient for wild-type spontaneous
reactivation. We also showed that in the context of the entire LAT
gene, deletion of LAT nucleotides 76 to 447 (LAT mutant
dLAT371) had no effect on spontaneous reactivation or
virulence. We report here on a LAT mutant designated LAT2.9A. This
mutant is similar to LAT3.3A, except that the ectopic LAT insert
contains the same 371-nucleotide deletion found in dLAT371.
We found that LAT2.9A had a significantly reduced rate of spontaneous
reactivation compared to marker-rescued and wild-type viruses. This was
unexpected, since the combined results of dLAT371 and
LAT3.3A predicted that spontaneous reactivation of LAT2.9A would be
wild type. We also found that LAT2.9A was more virulent than wild-type
or marker-rescued viruses after ocular infection of rabbits. This was
unexpected, since LAT null mutants and LAT3.3A have wild-type
virulence. These results suggest for the first time (i) that regions
past the first 1.5 kb of LAT can compensate for deletions in the first
1.5kb of LAT and may therefore play a role in LAT dependent spontaneous
reactivation and (ii) that regions of LAT affect viral virulence.
 |
INTRODUCTION |
After ocular herpes simplex virus
type 1 (HSV-1) ocular infection, the virus travels up nerves
to the trigeminal ganglia (TG), where it establishes a latent
infection. Latency lasts for the life of the infected individual. HSV-1
can reactivate from latency and travel back to the eye, where it can be
detected in tears and cause recurrent corneal disease. Recurrent ocular
HSV-1 can lead to scarring of the cornea and loss of sight. In
developed nations, HSV-1 is the most common cause of corneal blindness
due to an infectious agent (12). How HSV-1 establishes,
maintains, and reactivates from latency remains unknown.
The latency-associated transcript (LAT) is the only viral gene that is
abundantly transcribed during latency (20). LAT is located
in the long repeat region of the viral genome and thus is present in
two copies per genome. LAT is initially transcribed as an 8.3-kb RNA
(4, 26). This primary LAT transcript gives rise to a family
of LAT RNAs, including the very stable 2-kb LAT (20, 24,
25), which appears to be an intron produced by splicing
(6). LAT transcription-negative mutants have been shown to
reactivate poorly by explant or induced reactivation in the mouse
(9, 10, 21), by induced reactivation in the rabbit (1,
23), and by spontaneous reactivation in the rabbit (14,
17). Thus, LAT is essential for efficient, wild-type reactivation
from sensory neurons.
The mechanism by which LAT functions remains unknown. No LAT-encoded
protein has been detected during latency and there does not appear to
be a LAT open reading frame that is well conserved among LAT genes
capable of sustaining spontaneous reactivation (5). Thus, in
the absence of undetected, atypical splicing, it is unlikely that
LAT's function is due to a LAT protein. LAT's function also does not
appear to be due to antisense downregulation of the important
immediate-early gene ICP0, which LAT overlaps in an antisense
direction. We recently showed that the first 1.5 kb of LAT alone is
sufficient for wild-type levels of spontaneous reactivation
(17). This region does not overlap any portion of any known
HSV-1 gene.
Mapping a LAT spontaneous reactivation function to the first 1.5 kb of
LAT was done by inserting the LAT promoter and the first 1.5 kb of LAT
into an ectopic location in the genome of a LAT null mutant between
HSV-1 genes UL37 and UL38 (17). This completely restored
wild-type levels of spontaneous reactivation. Another LAT mutant,
dLAT371, containing a StyI-StyI
deletion that removed LAT nucleotides 76 to 447 was also wild type for
spontaneous reactivation (18). Thus, this 371-nucleotide
region within the first 1.5 kb of the primary LAT transcript did not
appear to be essential for efficient spontaneous reactivation.
We report here on a mutant that is a combination of LAT3.3A and
dLAT371. This virus, designated LAT2.9A, contains a LAT
insert at the same ectopic location as LAT3.3A. This insert is
identical to that in LAT3.3A (i.e., the LAT promoter and the first 1.5 kb of LAT), except that LAT nucleotides 76 to 447 are deleted. As with
LAT3.3A, the LAT promoter and the first 1.67 kb of LAT are deleted from
both copies of LAT in the long repeat and therefore the only LAT
produced originates from the ectopic insert. We predicted that LAT2.9A,
like LAT3.3A and dLAT371, would have wild-type spontaneous reactivation. Instead, LAT2.9A had a significantly reduced spontaneous reactivation rate that was comparable to that of the LAT null mutant
dLAT2903. LAT2.9A also was significantly more virulent than
wild-type virus. This was also unexpected, since dLAT2903, LAT3.3A, and dLAT371 all appeared to have wild-type virulence.
 |
MATERIALS AND METHODS |
Cells and virus.
Rabbit skin (RS) cells were grown in Eagle
minimal essential media (MEM) supplemental with 5% fetal calf serum
(FCS). CV-1 cells were grown in MEM supplemented with 10% FCS. CV-1
cells were used for growth kinetic studies. RS cells were used for all other tissue culture procedures, including the preparation of virus
stocks. All mutants were derived from HSV-1 strain McKrae. The parental
McKrae virus and all mutants were triple plaque purified and passaged
only one or two times prior to use. The construction and properties of
dLAT2903, LAT3.3A (previously designated LAT1.5a), and
dLAT371 have been previously described (14, 17,
18).
Construction of LAT2.9A.
The parental virus for this
construct was dLAT2093, a mutant of HSV-1 strain McKrae
containing a 1.8-kb (EcoRV-HpaI) deletion in both
copies of LAT that removed 0.2 kb of the LAT promoter and 1.6 kb of the
5' end of the primary 8.3-kb LAT transcript (14). The
previously cloned EcoRI A fragment from HSV-1 strain McKrae
(15) was digested with BamHI, and the products
were separated by agarose gel electrophoresis. A resulting 7.5-kb band
containing the McKrae genomic region including UL37 and UL38 was
isolated by electroelution and cloned into the BamHI site of
plasmid pEV-vrf3 (3, 15) to produce the plasmid pV375. pV375
was digested with AflII, the overhang was filled in using
the Klenow fragment, and the blunt ends were self-ligated to create a
unique PacI site in the plasmid between the sequences for
UL37 and UL38. The resulting plasmid, designated pV375Pac, was
amplified by transformation into Escherichia coli
RR1
CI857 according to standard protocol. An
HpaI-HpaI restriction fragment consisting of 1.8 kb of the LAT promoter and the first 1.5 kb of the LAT RNA
(17) was cloned into the PacI site of pNEB193 and
further digested with StyI to remove a 371-nucleotide
StyI-StyI region corresponding to LAT nucleotides
76 to 447. The plasmid was then self-ligated and digested with
PacI, and the resulting 2.9-kb band was cloned into the
PacI site of pV375Pac to produce pV375LAT2.9.
LAT2.9A was generated by homologous recombination as we previously
described (14, 17-19). Briefly, pV375LAT2.9 was
cotransfected with infectious dLAT2903 (the LAT deletion
mutant described above) DNA by the calcium phosphate method. Viruses
from the cotransfection were plated, and isolated plaques were picked
and screened for insertion of the 2.9-kb LAT fragment between UL37 and
UL38 by restriction digestion and Southern analysis. Selected plaques were triple plaque purified and reanalyzed by restriction digestion and
Southern analysis to ensure that the 2.9-kb fragment was present between UL37 and UL38 and that both long repeats retained the original
1.8-kb LAT deletion of the promoter and first 1.6 kb of the 5' end of
the primary LAT transcript (see Fig. 1 and 2). A final plaque was
purified and designated LAT2.9A (LAT2.9 indicated the 2.9-kb LAT
fragment; A indicates addition). The marker rescued virus LAT2.9AR, was
generated as described above by homologous recombination of LAT2.9A DNA
with the plasmid pV375LAT3.3. This restored the 371-nucleotide
StyI-StyI deletion in the ectopic LAT insert and
rescued LAT2.9A back to a wild-type LAT3.3A structure.
Replication of virus in tissue culture.
CV-1 cell monolayers
at approximately 70 to 80% confluency were infected with virus at 0.01 PFU/cell, and all monolayers were refed with exactly the same amount of
MEM containing 10% FCS. Virus was harvested for titration at various
times by two cycles of freeze-thawing the monolayers plus media
(
80°C to room temperature). The PFU/milliliter values were
determined by standard plaque assays on RS cells.
Rabbits.
Eight- to ten-week old New Zealand White female
rabbits (Irish Farms) were used for all experiments. Rabbits were
treated in accordance with ARVO (Association for Research in Vision and Ophthalmology), AALAC (American Association for Laboratory Animal Care), and NIH (National Institutes of Health) guidelines.
Rabbit model of ocular HSV-infection, latency, and spontaneous
reactivation.
Rabbits were bilaterally infected without
scarification or anesthesia by placing 2 × 105 PFU of
HSV-1 per eye into the conjunctival cul-de-sac, closing the eye, and
rubbing the lid gently against the eye for 30 s (20). At this dose of HSV-1 McKrae virtually all of the surviving rabbits harbor a bilateral latent HSV infection in both trigeminal ganglia, resulting in a high group rate of spontaneous reactivation with the
McKrae strain of HSV-1. Latency is assumed to have been established by
28 days postinfection. Acute ocular infection of all eyes was confirmed
by HSV-1 positive tear film cultures collected on days 3 and 4 postinfection.
Detection of spontaneous reactivation by ocular shedding.
Beginning on day 31 postinfection, tear film specimens were collected
daily from each eye for 26 days as previously described (22), using a nylon-tipped swab. The swab was then placed in 0.5 ml of tissue culture medium and squeezed, and the inoculated medium
was used to infect primary rabbit kidney cell monolayers. These cell
monolayers were observed in a masked fashion by phase light microscopy
for up to 30 days to monitor HSV-1 cytopathic effects (CPE). All
positive monolayers were blind passaged onto fresh cells to confirm the
presence of virus. DNA was purified from randomly selected positive
cultures derived from latently infected rabbits and analyzed by
restriction enzyme digestion and Southern blots to confirm that the CPE
was due to reactivated HSV-1 and that the reactivated virus was
identical to the input virus.
Virus replication in rabbit eyes.
Tear films were collected
as described above on various days postinfection. The amount of virus
in each tear film was determined by standard plaque assays on RS cells.
RT-PCR.
Reverse transcriptase (RT)-PCR was done as we
previously described (17) with minor modifications. Briefly,
RNA was isolated with Trizol (Gibco-BRL, Grand Island, N.Y.) from
individual TG from latently infected rabbits or from infected CV-1 cell
monolayers and treated with DNase I (12 U, 37°C, 30 min; Stratagene,
La Jolla, Calif.). RNA was isolated with an RNeasy Mini-Kit (Quiagen,
Santa Clarita, Calif.). The purified RNAs were subjected to
first-strand cDNA synthesis by Superscript II (Gibco-BRL) according to
the manufacturer's protocol. The primer for first-strand cDNA
synthesis from the LAT RNA was
5'-CTTTGTTGAACGACACCGGGGCGCCCTCGA-3'. The cDNA product was
then amplified by PCR with the primer
5'-CCACAACGGCCCGGCGCATGCGCTGTGGTT-3' and the first-strand
primer. These primers generate a 160-bp product specific for LAT
nucleotides 471 to 631. The amplified products were fractionated by gel
electrophoresis, transferred to a nylon membrane, and hybridized to the
32P-labeled internal probe
5'-TCTCCCCCCCCCCTTCTTCACCCCCAGTAC-3' corresponding to LAT
nucleotides 550 to 580.
Statistical analysis.
Statistical analyses were performed by
using Instat, a personal computer software program. For analyses with
either the Student t test, the Mann-Whitney rank sum test,
the chi-square test, or the Fisher exact test the results were
considered statistically significant when the P value was
<0.05.
 |
RESULTS |
Structure of LAT2.9A.
The genomic structures of wild-type
HSV-1 McKrae, LAT2.9A, and the other viruses used in this study are
shown in Fig. 1A. All
of the viruses were derived from HSV-1 strain McKrae. The construction
and properties of dLAT2903 and its marker-rescued virus
dLAT2903R, dLAT371 and its marker-rescued virus
dLAT371R, and LAT3.3A (previously designated LAT1.5a) have
been described previously (14, 17, 18). The LAT
transcript(s) made by each virus are detailed in Fig. 1B. Wild-type
McKrae and the marker-rescued viruses dLAT2903R and
dLAT371R contain two copies of LAT, one in each viral long
repeat (Fig. 1A, top). The viral long repeats are expanded (in dashed
lines) to show the relative location and status of the LAT gene. In the
topmost panel, the location of the ICP0 and ICP34.5 genes are shown for
reference. The primary LAT transcript in the wild-type and the
marker-rescued viruses is approximately 8.3 kb (Fig. 1A, top panel, and
Fig. 1B) (24, 25). A very stable and easily detected 2-kb
LAT (solid rectangle) appears to be an intron derived by splicing of
the primary LAT (6). dLAT2903 contains a deletion
in both copies of LAT from
161 to +1,667 relative to the start of the
primary LAT transcript (Fig. 1A, indicated by "XXXXX"). This virus
is missing key promoter elements, makes no LAT RNA (Fig. 1B), and is a
true LAT null mutant. dLAT371 contains a 371-nucleotide
deletion of LAT nucleotides 76 to 447, corresponding to a
StyI-StyI region prior to the 2-kb LAT (Fig. 1A,
third panel, indicated by "X"). This virus makes a normal primary
LAT transcript except that it is missing LAT nucleotides 76 to 447 (Fig. 1B). LAT3.3A is derived from dLAT2903 by insertion of
1.8 kb of the LAT promoter and the first 1.5 kb of LAT into a unique
PacI site that was constructed between UL37 and UL38 (Fig.
1A). LAT3.3A and LAT2.9AR make no LAT RNA from either copy of LAT in
the long repeats, but they do make a 1.5-kb LAT RNA from the ectopic
insert that corresponds to the first 1.5 kb of the primary LAT (Fig.
1B). LAT2.9A is identical to LAT3.3A, except that LAT nucleotides 76 to
447 have been deleted from the inserted 1.5-kb LAT region (Fig. 1A).
LAT2.9A therefore transcribes an RNA of 1,128 nucleotides corresponding
to LAT nucleotides 1 to 76 and 447 to 1,499. The construction of all
the above mutants except LAT2.9A and LAT2.9AR have been previously
described (14, 17, 18). Additional details of the
construction of LAT2.9A and LAT2.9AR are given in Materials and
Methods.

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 1.
Construction and structure of LAT2.9A. (A) The top panel
(wt McKrae, dLAT2903R, and dLAT371R) shows a
schematic representation of the genome of wild-type McKrae and the
wild-type marker-rescued viruses dLAT2903R and
dLAT371R, which are identical to wild-type HSV-1. The
prototypic orientation of HSV-1 shown here contains a unique long
region and a unique short region, each bounded by inverted repeats. The
unique regions are shown as solid lines. The repeats are shown as open
rectangles. UL, unique long; US, unique short;
TRL, terminal repeat long; IRL, internal repeat
long; IRS, internal repeat short; TRS, terminal
repeat short. The lines with arrows under the genome indicate the
locations and directions of the LAT, ICP34.5, and ICP0 transcripts. The
solid rectangle within the primary 8.3-kb LAT transcript indicates the
location of the stable 2-kb LAT. TATA indicates the location (in the
genomic DNA) of the LAT promoter TATA box. The next panel shows that
dLAT2903, the previously described LAT null mutant
(14), has a deletion extending from LAT nucleotides 161 to
+1667. This deletion encompasses the LAT promoter, and
dLAT2903 therefore cannot transcribe any LAT RNA. The dashed
rectangle and the preceding dashed line covered by "XXXXX"
represent the portion of LAT that is deleted from both long repeats.
Panel dLAT371 shows a previously described mutant containing
a deletion of LAT nucleotides 767 to 447 in both copies of LAT (18). The blow-up in panel
LAT3.3A and LAT2.9R shows the location of the 3.3-kb LAT fragment
inserted between genes UL37 and UL38 in the unique long region of the
LAT deletion mutant dLAT2903 to generate the virus LAT3.3A
(17). The insert contains 1.8 kb of the LAT promoter and the
first 1.5 kb of the primary LAT. The insertion site is outside the
domains of the UL37 and UL38 promoters, and these genes are not
affected (17). The structure of LAT2.9AR, a marker-rescued
virus derived from LAT2.9A (see below) is identical to LAT3.3A. Panel
LAT2.9A shows that LAT2.9A contains the same insert between UL37 and
Ul38 as LAT3.3A, except that the StyI-StyI region
(LAT nucleotides 76 to 447) has been deleted from the insert. This
deletion corresponds to the deletion in dLAT371 described
above. (B) The LAT RNAs made by each of the viruses shown in panel A
are indicated. Wild-type McKrae, dLAT2903R, and
dLAT371R all make the complete primary LAT transcript. The
solid rectangle starting at LAT nucleotide 662 indicates the location
of the stable 2-kb LAT. dLAT2903 makes no LAT RNA.
dLAT371 transcribes all of the LAT except nucleotides 76 to
447. LAT3.3A and LAT2.9AR make no LAT from the original LAT region (one
in each long repeat), but they do transcribe the first 1.5 kb of LAT
from the LAT insert between UL37 and UL38. LAT2.9A also makes not LAT
from the original LAT region. It transcribes LAT nucleotides 1 to 76 and 447 to 1499 (i.e., the first 1.5 kb of LAT minus the
StyI-StyI region).
|
|
Southern analysis of the structure of LAT2.9A.
Southern
analyses of viral DNAs were performed to confirm the structure of
LAT2.9A (Fig. 2). DNAs were individually
digested with PacI and probed with a 32P-labeled
restriction fragment (StyI-HpaI; LAT nucleotides
447 to 1,499) that is completely within the LAT region deleted in dLAT2903 and that therefore can hybridize only with LAT
sequences in the LAT2.9A insert (Fig. 2A). The wild-type virus (lane 1) produced a single large band of genome size as expected, since PacI does not cut wild-type HSV-1. The dLAT2903
DNA produced no band (lane 2), since the sequences corresponding to the
probe are deleted from this virus. PacI should cut the
PacI sites flanking the 2.9-kb LAT fragment inserted between
UL37 and UL38 in LAT2.9A to produce a single band of 2.9 kb that
hybridizes to the probe as is seen in lane 3. Similarly,
PacI cuts the correspondingPacI sites in LAT2.9AR
and LAT3.3A, producing bands of 3.3 kb (lanes 4 and 5). These results
indicate that LAT2.9A contains the expected 2.9-kb LAT insert between
UL37 and UL38 and that the corresponding region in LAT2.9AR has been
rescued back to the wild-type size (lane 4) seen in LAT3.3A (lane 5).

View larger version (92K):
[in this window]
[in a new window]
|
FIG. 2.
Southern analysis of LAT2.9A. (A) Viral DNAs were
isolated, individually digested with PacI, and hybridized to
a 32P-labeled probed corresponding to part of the LAT
region deleted in dLAT2903 but present in wild-type McKrae
and the LAT insert in LAT2.9A (see text). (B) The viral DNAs were
digested with BamHI and probed with the BamHI-H
restriction fragment that hybridizes to the UL37-UL38 region, but not
to LAT (see text). (C) The viral DNAs were digested with
BamHI and probed with a cloned
HpaI-MluI restriction fragment corresponding to
LAT nucleotides 1,667 to 2850 (see the text) that should hybridize to
LAT DNA from the long repeats but not to the LAT inserts in the
UL37-UL38 region (see text). Lanes: 1, wild-type McKrae; 2, dLAT2903; 3, LAT2.9A; 4, LAT2.9AR; 5, LAT3.3A.
|
|
The viral DNAs in Fig. 2B were digested with BamHI and
probed with the BamHI H restriction fragment that hybridizes
to the UL37-UL38 region but not to any of the LAT sequences (see top of Fig. 1 for location of BamHI H). Both wild type (lane 1)
and dLAT2903 (lane 2) show a single band of 7.5 kb
corresponding in size to the BamHI H restriction fragment
containing UL37 and UL38. Lanes 3, 4, and 5 contain only a
slower-migrating band of 10.4 or 10.8 kb, corresponding to
BamHI H plus the 2.9- or 3.3-kb LAT insert. This again
indicates that LAT2.9A contains the appropriate LAT fragment inserted
between UL37 and UL38. The 371-nucleotide difference between the
10.4-kb LAT2.9A band and the 10.8-kb LAT2.9AR and LAT3.3A bands cannot
be distinguished because of their relatively large size compared to the deletion.
The viral DNAs in Fig. 2C were also digested with BamHI but
were hybridized to a probe specific for a region of LAT that is present
in wild type and dLAT2903 but not in the LAT insert of LAT2.9A or LAT3.3A (a cloned HpaI-MluI
restriction fragment corresponding to LAT nucleotides 1,667 to 2,850).
This probe should hybridize only to the BamHI B and
BamHI E restriction fragments generated from the long
repeats (one from each repeat; locations shown at the top of Fig. 1)
that contain the HSV-1 sequence corresponding to the probe. As seen in
Fig. 2C, lane 1, these two bands are of different sizes because in both
restriction fragments one BamHI cut is in the repeat and one
is in the adjacent unique long region. The larger band contains LAT
from the internal repeat, while the smaller band is from the terminal
repeat. Both of these bands are smaller in the original LAT deletion
mutant, dLAT2903 (lane 1) and in LAT2.9A, LAT2.9AR, and
LAT3.3A, (lanes 3 to 5), a finding indicative of the 1.8-kb LAT
deletion in each long repeat in these viruses. This confirms that in
these viruses the original LAT deletion was retained in both original
copies of LAT and that these viruses are therefore incapable of
transcribing any LAT RNA from either normal LAT gene. Combined, the
Southern analyses shown in Fig. 2 confirm the structure of the LAT2.9A
and LAT2.9AR viruses.
In vitro replication of LAT2.9A. Monolayers of CV-1 cells
were infected with 0.01 PFU of LAT2.9A, wild-type McKrae, LAT3.3A,
dLAT2903, or dLAT2903R per cell. The monolayers
were harvested by freeze-thawing at the indicated times (Fig.
3A), and the virus yield was determined
by standard plaque assays as described in Materials and Methods. As
we previously showed (14, 17), replication of
LAT3.3A, dLAT2903, and dLAT2093R, were all wild type in tissue culture. LAT2.9A also replicated with wild-type kinetics.

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 3.
Replication of LAT2.9A (A) Semiconfluent monolayers of
CV-1 cells were infected with 0.01 PFU of the indicated virus per cell.
At various times, the infected cell monolayers were harvested by
freeze-thawing and the amount of virus was determined by plaque assay
on RS cells. Each time point is the average of two determinations. (B)
Tear swabs were performed on the eyes of rabbits infected with the
indicated virus at various times postinfection. The amount of virus
present in individual tear swabs was determined by plaque assay on RS
cells. Each point represents the mean titer from five eyes, each from a
different rabbit. Error bars indicate the standard deviation.
|
|
In vivo replication of LAT2.9A.
Rabbits were infected with
2 × 105 PFU of LAT2.9A, dLAT2903,
dLAT2903R, or LAT3.3A per eye. Tears were collected at the
indicated times (Fig. 3B), and the virus yield was determined by plaque assay. As we have previously shown (14, 17), replication of dLAT2903 and LAT3.3A in rabbit eyes was similar to that of
wild type (dLAT2903R) virus. Replication of LAT2.9A (Fig.
3B, open circles) appeared to be slightly lower than that of LAT3.3A
and dLAT2903R (solid circles and squares) on days 3 and 5 but not on
day 7. However, as indicated by the overlapping error bars, these minor
differences were not significant.
Reduced survival of rabbits ocularly infected with LAT2.9A.
Eighteen rabbits per group were infected with 2 × 105
PFU of LAT2.9A, dLAT2903, dLAT2903R, or LAT3.3A
per eye. Only 17% of the LAT2.9A-infected rabbits survived for 21 days
(Table 1, experiment 1, column 3) compared to 33-39% survival for the
other groups. Since dLAT2903, dLAT2903R, and
LAT3.3A all have wild type parental McKrae virulence in rabbits
(14, 17), it appeared that survival of LAT2.9A may have been
reduced compared to wild type. However, the differences were not
significant (Table 1, experiment 1, column 4). To determine if the tendency in experiment 1 for LAT2.9A to
be more virulent than wild type was meaningful, additional experiments
were done. In a second experiment, 22 rabbits per group were infected
with LAT2.9A or dLAT2903R (Table 1, experiment 2). Again,
the percentage of rabbits surviving infection with LAT2.9A appeared to
be reduced compared to wild type (32 versus 55%). However, as in
experiment 1, the differences was not statistically significant (Table
1, column 3).
In a third experiment, 16 rabbits were infected per group. This
experiment included dLAT371 and its rescued virus,
dLAT371R, as controls, since dLAT371 contains the
same StyI-StyI deletion as LAT2.9A (Fig. 1). In
addition, a marker-rescued version of LAT2.9A, designated LAT2.9AR, was
included to determine if the apparent reduced virulence of LAT2.9A
corresponded to the StyI-StyI deletion. Again,
LAT2.9A appeared to be more virulent than each of the other groups
(Table 1, experiment 3, column 3) although statistical
significance was only reached between LAT2.9A and dLAT371R (Table 1, experiment 3).
Because the same pattern of a tendency toward increased virulence of
LAT2.9A was seen in all experiments and between LAT2.9A and each of the
wild-type or rescued groups within each experiment, it was
statistically meaningful to compile and compare the totals (Table 1).
Of 56 rabbits infected with LAT2.9A, only 25% survived. In contrast,
47% of 106 rabbits infected with wild-type virus, marker-rescued
virus, or mutants with wild-type virulence survived. This difference
was significant (P = 0.007). It was also of interest to
compare LAT2.9A to dLAT2903, a virus that makes no LAT,
since LAT2.9A is derived directly from dLAT2903. For this
purpose, we compiled the results of experiment 1 with those of the four
most recent experiments in our laboratory in which dLAT2903
had been included as a negative control for spontaneous reactivation.
Like the wild-type viruses (P = 0.76; not shown), but
in contrast to LAT2.9A (P = 0.006), 50% of the 68 dLAT2903-infected rabbits survived. These results strongly
suggest that LAT2.9A was more virulent than either wild-type or
LAT-negative viruses.
Reduced spontaneous reactivation of LAT2.9A.
Beginning at 31 days postinfection (at which time latency had already been
established), all eyes from the surviving rabbits in experiments 1, 2, and 3 were swabbed once a day for 26 days to collect tear films for
analysis of reactivated virus as described in Materials and Methods. In
experiment 1, LAT2.9A was compared to dLAT2903, which has
reduced spontaneous reactivation, and to LAT3.3A and
dLAT2903R, both of which have spontaneous reactivation rates
identical to wild-type McKrae. The cumulative number of virus-positive
tear film cultures is shown in Fig. 4A.
Because of the different numbers of surviving rabbits in the different groups, the data were standardized to represent cumulative positive cultures per eye. The cumulative spontaneous reactivation rate in
rabbits latently infected with LAT2.9A (Fig. 4A, open circles; approximately 1.8/eye on day 26) appeared to be less than
dLAT2903R and LAT3.3A (Fig. 4A, solid squares and circles;
approximately 3 to 3.5/eye) and slightly greater than
dLAT2903 (Fig. 4A, open squares; approximately 1/eye).

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 4.
Spontaneous reactivation of LAT2.9A. Each panel shows an
independent experiment, each of which was performed at a different
time. Rabbits were infected with 2 × 105 PFU of the
indicated virus per eye. Rabbits surviving past day 21 are considered
to have a latent HSV-1 infection in both TG. Beginning 31 days
postinfection (day 1 of the collection period), tear swabs were
collected daily for 26 days from all eyes and plated on RS to look for
the presence of spontaneously reactivated virus. The cumulative number
of virus-positive cultures divided by the number of eyes in the group
is shown. Panels A, B, and C indicate the results of experiment 1, 2, and 3, respectively. dLAT2903R, LAT3.3A,
dLAT371R, all of which have previously been shown to have
wild-type McKrae spontaneous reactivation rates, were used as positive
controls in various experiments.
|
|
The cumulative data for positive (spontaneously reactivated) cultures
versus total cultures (Table 2,
experiment 1, column 3) indicated that 7.1% of the tear film cultures
from rabbits latently infected with LAT2.9A virus contained
spontaneously reactivated virus compared to 3.6% of the tears from
eyes infected with dLAT2903. In contrast, 12.2 and 13.7% of
tears from eyes infected with LAT3.3A and dLAT2903R,
respectively, contained spontaneously reactivated virus. Thus, based on
total cultures, without regard to the number of eyes, LAT2.9A appeared
to reactivate less well than the wild-type viruses. However, in this
experiment, the percentages of eyes that reactivated at least once were
similar for LAT2.9A and the wild-type viruses (Table 1).
The analysis and interpretation of the results of experiment 1 were
greatly handicapped by the fact that only three of the LAT2.9A-infected
rabbits survived. Based on our previous experience, this was too small
a number for meaningful comparisons and statistical analyses are not
shown. Additional data was obtained from experiments 2 and 3 (Fig. 3B
and C; Table 1), both of which contained more surviving rabbits in most
groups. In experiment 2, the cumulative spontaneous reactivation rate
in rabbits latently infected with LAT2.9A appeared to be decreased
compared to dLAT2903R (Fig. 3B, open circles compared to
solid circles; approximately 0.4/eye versus 2.2/eye). The number of
positive eye cultures versus total eye cultures (Table 2, experiment 2, column 3) indicated only 1.6% of the tear film cultures from rabbits
latently infected with LAT2.9A virus contained spontaneously
reactivated virus compared to 8.3% of the tears from eyes infected
with dLAT2903R. This difference was highly significant
(Table 2, experiment 2, column 4). Because the above analysis did not
take into account the number of eyes in each of the groups, the data
were also analyzed as follows. The fraction of virus-positive cultures
for each eye in each group (i.e., the fraction of time each eye was
virus positive) was calculated, and these fractions were analyzed by
the Mann-Whitney rank sum test (Table 2, experiment 2, column 5). By
this analysis, LAT2.9A also reactivated less well than
dLAT2903R. The percentage of eyes that reactivated at least
once in the LAT2.9A group was also significantly reduced compared to
wild type (dLAT2903R) (Table 2, experiment 2, columns 6 and 7).
In experiment 3, the cumulative spontaneous reactivation rate in
rabbits latently infected with LAT2.9A also appeared to be decreased
compared to that of dLAT371 and dLAT371R (Fig.
4C). Both of these viruses have wild-type spontaneous reactivation rates (18). LAT2.9A was compared to dLAT371 in
this experiment since, although dLAT371 transcribes the
entire primary LAT while LAT2.9A only transcribes up to nucleotide
1,499, both viruses contain the same StyI-StyI
deletion. The number of positive eye cultures versus total eye cultures
(Table 2, experiment 3, column 3) indicated that only 0.5% of the
LAT2.9A tear film cultures were positive, while 12 and 11% of the
dLAT371 and dLAT371R cultures were positive. This
reduction in LAT2.9A spontaneous reactivation was highly significant
(Table 2, experiment 3, column 4). Analysis of the fraction of time
each eye was positive for reactivated virus also indicated that the
reduction in LAT2.9A spontaneous reactivation was significant compared
to dLAT371 and dLAT371R (Table 2, experiment 3, column 5). The percentage of eyes that reactivated was also
significantly reduced in LAT2.9A compared to dLAT371R (Table
2, experiment 3, columns 6 and 7). The lack of significance between
LAT2.9A and dLAT371 was probably due to the small number of
rabbits in the dLAT371 group.
To confirm that the apparent decreased spontaneous reactivation of
LAT2.9A was not due to an undetected, unrelated, mutation in the virus,
LAT2.9A was marker rescued by using a restriction fragment containing
the intact first 1.5 kb of LAT as described in Materials and Methods.
This rescuing fragment restored the StyI-StyI
deletion in the 1.5-kb LAT insert in the unique long region of LAT2.9A.
The deletion in both original copies of LAT was retained (see Fig. 2C).
Assuming that there was no extraneous, undetected, spontaneous mutation
elsewhere in the virus, LAT2.9AR should be structurally identical to
LAT3.3A. The cumulative spontaneous reactivation rate in rabbits
latently infected with LAT2.9AR appeared to be similar to that of
dLAT371R and dLAT371 (Fig. 4C; 2.6 versus 2.9 and
3.1 positive cultures/eye on days 26). The number of positive eye
cultures versus total eye cultures (Table 2, experiment 3, column 3)
also indicated that LAT2.9AR was restored to wild-type levels (9.9%
versus 11 and 12% for the dLAT wild-type viruses) and that
spontaneous reactivation of LAT2.9AR was significantly greater than
that of LAT2.9A (P < 0.001 and P = 0.01; Table 2, experiment 3, columns 4 and 5). Finally, the
percentage of LAT2.9AR eyes that reactivated was similar to
dLAT371 and dLAT371R (Table 2, experiment 3, columns 6 and 7; 71% compared to 67 to 68%) and greater than LAT2.9A
(71% versus 12.5%; P = 0.02).
The totals of all three experiments were analyzed for spontaneous
reactivation as they had been for virulence. In Table 2, as in Table 1,
the wild-type viruses contain the results for all of the viruses
designated "wt" combined with the results for the LAT2.9AR
marker-rescued virus, while the dLAT2903 totals reflect the
results of experiment 1 plus the combined totals of the last four
experiments in our laboratory, in which dLAT2903 was used as
a negative spontaneous reactivation control. The decreased spontaneous
reactivation of LAT2.9A compared to wild type was highly significant
for each of the parameters analyzed (Table 1, totals, columns 4, 5, and
7). In addition, the spontaneous reactivation rate of LAT2.9A was
similar to that of the LAT null mutant dLAT2903 for all of
the parameters. Thus, LAT2.9A was impaired for spontaneous reactivation
and had a spontaneous reactivation phenotype indistinguishable from
that of a LAT null mutant. Southern analyses of selected spontaneously
reactivated virus detected in tears confirmed that the reactivated
viruses were structurally unchanged from the infecting viruses (data
not shown).
Transcription of LAT in tissue culture and the TG of rabbits
latently infected with LAT2.9A.
To confirm that transcription of
LAT in LAT2.9A was as expected, RT-PCR analyses were done. CV-1 cells
were infected at a multiplicity of infection of 2, and RT-PCR was
performed on total RNA. The primers used generate a 160-bp product
specific for LAT nucleotides 471 to 631. The RT-PCR products were
subjected to Southern analysis by using an internal
32P-labeled probe (LAT nucleotides 550 to 580) (Fig.
5A). As expected, a 160-bp RT-PCR product
was detected in cells infected with dLAT371, LAT3.3A, or
LAT2.9A (Fig. 5A). In addition, the apparent intensity of the RT-PCR
bands in each lane was similar. Since we previously showed that the
amount of LAT RNA in TG latently infected with dLAT371 or
LAT3.3A is similar to that of wild-type McKrae (17, 18),
these results suggest that in tissue culture the predicted LAT2.9A RNA
was present in wild-type amounts. No RT-PCR product was produced from
dLAT2903-infected cells, confirming that RNA corresponding
to this region of LAT was not made by the dLAT2903 LAT null
mutant.

View larger version (29K):
[in this window]
[in a new window]
|
FIG. 5.
Transcription of LAT in tissue culture cells and in
rabbits latently infected with LAT2.9A. (A) CV-1 cell monolayers were
infected with the indicated viruses at a multiplicity of infection of
2, and the total RNA was isolated, RT-PCR was performed with primers
corresponding to LAT nucleotides within the predicted LAT2.9A RNA, and
Southern analysis was performed with an internal
32P-labeled probe as described in Materials and Methods.
(B) Total RNA was isolated from individual TG from rabbits latently
infected with the indicated virus, and RT-PCR analyses were performed
and analyzed by Southern analysis as above. Each lane shows the RT-PCR
product from one TG. The lane labeled ddH2O is a negative
control. The RT-PCR analyses shown in the last three lanes were done at
a different time than the other analyses.
|
|
To confirm that LAT2.9A transcription was as predicted during latency,
total RNA was prepared from the individual TG of latently infected
rabbits. RT-PCR analyses were performed as described above. As we
previously reported (17), a 160-bp RT-PCR product was
detected in the TG from rabbits latently infected with LAT3.3A, while
no RT-PCR product was detected in rabbits latently infected with
dLAT2903 (Fig. 5B). The same RT-PCR product was also seen in
the TG from rabbits latently infected with LAT2.9A (Fig. 5B). We
previously showed that the amount of LAT RNA in individual TG from
rabbits latently infected with the same virus can vary significantly
when analyzed by either RT-PCR (17, 18) as done here or by
in situ hybridization (20). Thus, the apparent different intensities of the RT-PCR bands in the two LAT2.9A lanes (Fig. 5B) was
similar to the differences previously seen with other viruses. The
similar intensity of the RT-PCR product in the rightmost LAT2.9A lane
and the LAT3.3A lane (Fig. 5B), therefore, strongly suggests that the
amount of LAT2.9A LAT present in latently infected TG was similar to
that of LAT3.3A LAT. Thus, the unexpected LAT2.9A phenotype did not
appear to be due to unexpected aberrations in LAT transcription.
 |
DISCUSSION |
In the experiments reported here, LAT2.9A had increased virulence
(based on reduced rabbit survival) and decreased spontaneous reactivation. In contrast, its marker-rescued virus, LAT2.9AR, was wild
type for both phenotypes. This very strongly suggests that the
increased virulence and the decreased spontaneous reactivation of
LAT2.9A were both due to the 371-nucleotide
StyI-StyI deletion. Both of these phenotypes were unexpected.
In contrast to the StyI-StyI deletion in LAT2.9A,
we previously showed that deletion of the
StyI-StyI region in the context of the entire LAT
gene (dLAT371) (18) did not effect spontaneous reactivation. In addition, we previously showed that insertion of the
LAT promoter and the first 1.5 kb of LAT (LAT 3.3A) into an ectopic
location in the LAT null mutant dLAT2903 restored wild-type spontaneous reactivation (17). LAT2.9A is identical to
LAT3.3A except that it contains the StyI-StyI
deletion. Thus, it was expected that LAT2.9A would have a wild-type
rate of spontaneous reactivation.
Possible explanations for the reduced reactivation of LAT2.9A fall into
at least three categories. (i) The first is the LAT copy number. It is
possible that the StyI-StyI region is not
essential for wild-type spontaneous reactivation when two copies of LAT are present in the genome. (ii) The second is the LAT location. It is
possible that when LAT is located in its normal location in the long
repeats, the StyI-StyI region is not required,
but the StyI-StyI region is required for LAT
function when LAT is not in its normal location. (iii) The third is the
lack of LAT from 1.5 to 8.3 kb. The StyI-StyI
region may not be required in the context of the otherwise-complete LAT
gene, but it is needed when only the first 1.5 kb of LAT is present.
This would suggest that there are one or more additional functional
regions downstream of the first 1.5-kb region. Since both
dLAT371 and LAT3.3A have wild-type rates of spontaneous
reactivation, the region pre-1.5 kb and the region post-1.5 kb must
each be able to produce wild-type levels of spontaneous reactivation,
but the effects of this must not be additive. This would easily occur
if each functional region resulted in the maximum spontaneous
reactivation possible in the rabbit model. Although not easily detected
in animal models, the presence of multiple independent functional
regions within LAT may have beneficial effects in nature. It would also
help explain why selective pressure has maintained the entire 8.3-kb
LAT gene in all of the HSV-1 isolates examined, despite the fact that
the first 1.5 kb of LAT alone is sufficient for maximum levels of spontaneous reactivation in the rabbit. Alternatively, functional regions after the first 1.5 kb of LAT may not be fully independently able to produce wild-type levels of spontaneous reactivation but may be
able to compensate for the StyI-StyI deletion in
the first 1.5 kb of LAT, perhaps via interactions with part of the
remaining 1.5-kb region. It is also possible that a previously
undetected splicing event occurs, either partially or completely within
the StyI-StyI region, and that this splicing is
required for LAT function in the context of the first 1.5 kb but that
it can be compensated for by sequences downstream of the first 1.5 kb.
Although LAT may partially inhibit productive gene expression (2,
7, 11), there have been no previously reports of any LAT mutants
with increased virulence. Over the course of numerous experiments in
our laboratory, the virulence of the LAT null mutant, dLAT2903 (14), has always been similar to that of
its wild-type parent. In addition, the virulence of LAT3.3A has been
indistinguishable from that of both its direct parent,
dLAT2903, and dLAT2903's wild-type McKrae parent
(17). In contrast, LAT2.9A, which is effectively a deletion
of the StyI-StyI region from LAT3.3A, had significantly increased virulence. Moreover, the increased virulence of
LAT2.9A was restored to the less-virulent wild-type level
by rescue of the StyI-StyI deletion in
the ectopic insert (LAT2.9AR). Thus, the increased virulence of
LAT2.9A appeared to be due to the 371-nucleotide
StyI-StyI deletion in its ectopic LAT insert.
Why does the deletion of LAT nucleotides 76 to 447 in LAT2.9A increase
virulence when the deletion of LAT nucleotides
161 to +1667
(dLAT2903) does not? Asked another way, why does the insertion of LAT nucleotides
1800 to +76 plus 447 to 1667 between UL37 and UL38 in dLAT2903 increase virulence, whereas the
insertion of LAT nucleotides
1800 to +1667 does not? or, from yet
another perspective, why does preventing transcription of LAT
nucleotides 76 to 447 along with LAT nucleotides 1667 to 8323 increase
virulence, whereas preventing all LAT transcription does not alter
virulence? This phenomenon, in which a small deletion has a larger
effect than a larger deletion that encompasses the smaller deletion, is
reminiscent of results often seen when mapping promoter activity. This
is because promoters often contain numerous functional elements, some
of which work in concert and some of which act antagonistically. A
series of deletions that removes successively larger regions of the 5'
end of a promoter often produces a pattern of promoter activity that
increases and decreases several times before all activity is gone.
Since it is unlikely that LAT encodes a protein and since deletion of
the StyI-StyI region does not appear to alter the
expression of LAT itself, this parallel suggests that the LAT RNA may
regulate the expression or function of one or more viral and/or
cellular genes. This regulation could be direct or through the
intervention of other gene products. In either situation, LAT could
enhance spontaneous reactivation by being a key factor involved in
intricate, controlled regulation of viral and/or cellular genes
involved in the latency-reactivation cycle.
We previously reported that d34.5, a McKrae-based mutant
deleted for both copies of
34.5, the gene for ICP34.5 (one in each long repeat), had dramatically decreased virulence and poor spontaneous reactivation after infection of rabbits with 2 × 105
PFU/eye (19). However, after an extremely high-dose ocular infection with over 108 PFU/eye, d34.5 was still
avirulent but its spontaneous reactivation rate was wild type
(16). A second mutant, derived from d34.5 and
designated d34.5A, contains one copy of
34.5 inserted
into the same ectopic location used for LAT2.9A. d34.5A, has
wild-type spontaneous reactivation while remaining much less virulent
than wild type (13). These previous studies showed that
decreased virulence does not necessarily result in decreased
spontaneous reactivation. The results reported here extend and
complement the above findings by showing that increased virulence does
not necessarily result in increased spontaneous reactivation. In 2.9A, increased virulence did not result in increased spontaneous
reactivation and, in fact, was coincident with decreased spontaneous
reactivation. These results confirm that the phenotypes for spontaneous
reactivation and virulence are separable.
Nonetheless, since LAT2.9A shows that LAT affects virulence as well as
reactivation, is of interest to consider the possibility that in this
mutant the increased virulence and the decreased spontaneous
reactivation were related. It is possible that the increased virulence
resulted in the elimination of neurons that would otherwise have become
latently infected. This might result in fewer surviving latently
infected neurons, resulting in a smaller pool of latently infected
neurons capable of reactivation. This, in turn, would be expected to
result in reduced spontaneous reactivation. Thus, one possible
hypothesis that could be derived from these studies is that the normal
function of LAT is to protect acutely infected neurons from death,
thereby producing a larger pool of latently infected neurons. This
larger pool of latently infected neurons would subsequently allow for
increased spontaneous reactivation. Consistent with this, it has been
proposed that the bovine herpes virus LR-RNA (latency-related RNA,
comparable to LAT) encodes products that promote neuronal survival
(8, 22). Unfortunately, in the rabbit model it has not yet
been possible to detect decreased amounts of latent viral DNA or
decreased numbers of latent viral DNA-positive neurons in the TG
(13), and so this hypothesis remains to be tested.
 |
ACKNOWLEDGMENTS |
This work was supported by Public Health Service grants EY07566
and EY10243, the Discovery Fund for Eye Research, and the Skirball
Program in Molecular Ophthalmology.
We thank Anita Avery for her expert technical support.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Ophthalmology
Research Laboratories, Cedars-Sinai Medical Center Burns & Allen
Research Institute, Davis Bldg., Rm. 5072, 8700 Beverly Blvd., Los
Angeles, CA 90048. Phone: (310) 855-6457. Fax: (310) 652-8411. E-mail: Wechsler{at}CSMC.edu.
 |
REFERENCES |
| 1.
|
Bloom, D. C.,
G. B. Devi-Rao,
J. M. Hill,
J. G. Stevens, and E. K. Wagner.
1994.
Molecular analysis of herpes simplex virus type 1 during epinephrine-induced reactivation of latently infected rabbits in vivo.
J. Virol.
68:1283-1292[Abstract/Free Full Text].
|
| 2.
|
Chen, S. H.,
M. F. Kramer,
P. A. Schaffer, and D. M. Coen.
1997.
A viral function represses accumulation of transcripts from productive-cycle genes in mouse ganglia latently infected with herpes simplex virus.
J. Virol.
71:5878-5884[Abstract].
|
| 3.
|
Crowl, R.,
C. Seamans,
P. Lomedico, and S. McAndrew.
1985.
Versatile expression vectors for high-level synthesis of cloned gene products in Escherichia coli.
Gene
38:31-38[Medline]. (Erratum, 45:117, 1986.)
|
| 4.
|
Dobson, A. T.,
F. Sederati,
G. Devi-Rao,
W. M. Flanagan,
M. J. Farrell,
J. G. Stevens,
E. K. Wagner, and L. T. Feldman.
1989.
Identification of the latency-associated transcript promote by expression of rabbit beta-globin mRNA in mouse sensory nerve ganglia latently infected with a recombinant herpes simplex virus.
J. Virol.
63:3844-3851[Abstract/Free Full Text].
|
| 5.
|
Drolet, B. S.,
G. C. Perng,
J. Cohen,
S. M. Slanina,
A. Yukht,
A. B. Nesburn, and S. L. Wechsler.
1998.
The region of the herpes simplex virus type 1 LAT gene involved in spontaneous reactivation does not encode a functional protein.
Virology
242:221-232[Medline].
|
| 6.
|
Farrell, M. J.,
A. T. Dobson, and L. T. Feldman.
1991.
Herpes simplex virus latency-associated transcript is a stable intron.
Proc. Natl. Acad. Sci. USA
88:790-794[Abstract/Free Full Text].
|
| 7.
|
Garber, D. A.,
P. A. Schaffer, and D. M. Knipe.
1997.
A LAT-associated function reduces productive-cycle gene expression during acute infection of murine sensory neurons with herpes simplex virus type 1.
J. Virol.
71:5885-5893[Abstract].
|
| 8.
|
Jiang, Y.,
A. Hossain,
M. T. Winkler,
T. Holt,
A. Doster, and C. Jones.
1998.
A protein encoded by the latency-related gene of bovine herpesvirus 1 is expressed in trigeminal ganglionic neurons of latently infected cattle and interacts with cyclin-dependent kinase 2 during productive infection.
J. Virol.
72:8133-8142[Abstract/Free Full Text].
|
| 9.
|
Leib, D. A.,
C. L. Bogard,
M. Kosz-Vnenchak,
K. A. Hicks,
D. M. Coen,
D. M. Knipe, and P. A. Schaffer.
1989.
A deletion mutant of the latency-associated transcript of herpes simplex virus type 1 reactivates from the latent state with reduced frequency.
J. Virol.
63:2893-2900[Abstract/Free Full Text].
|
| 10.
|
Leib, D. A.,
K. C. Nadeau,
S. A. Rundle, and P. A. Schaffer.
1991.
The promoter of the latency-associated transcripts of herpes simplex virus type 1 contains a functional cAMP-response element: role of the latency-associated transcripts and cAMP in reactivation of viral latency.
Proc. Natl. Acad. Sci. USA
88:48-52[Abstract/Free Full Text].
|
| 11.
|
Mador, N.,
D. Goldenberg,
O. Cohen,
A. Panet, and I. Steiner.
1998.
Herpes simplex virus type 1 latency-associated transcripts suppress viral replication and reduce immediate-early gene mRNA levels in a neuronal cell line.
J. Virol.
72:5067-5075[Abstract/Free Full Text].
|
| 12.
|
Nesburn, A. B. (ed.).
1983.
Report of the Corneal Disease Panel: vision research: a national plan 1983-1987, vol. II, part III.
C. V. Mosby Co., St. Louis, Mo.
|
| 13.
|
Perng, G. C.,
K. Chokephaibulkit,
R. L. Thompson,
N. M. Sawtell,
S. M. Slanina,
H. Ghiasi,
A. B. Nesburn, and S. L. Wechsler.
1996.
The region of the herpes simplex virus type 1 LAT gene that is colinear with the ICP34.5 gene is not involved in spontaneous reactivation.
J. Virol.
70:282-291[Abstract].
|
| 14.
|
Perng, G. C.,
E. C. Dunkel,
P. A. Geary,
S. M. Slanina,
H. Ghiasi,
R. Kaiwar,
A. B. Nesburn, and S. L. Wechsler.
1994.
The latency-associated transcript gene of herpes simplex virus type 1 (HSV-1) is required for efficient in vivo spontaneous reactivation of HSV-1 from latency.
J. Virol.
68:8045-8055[Abstract/Free Full Text].
|
| 15.
|
Perng, G. C.,
H. Ghiasi,
R. Kaiwar,
A. B. Nesburn, and S. L. Wechsler.
1994.
An improved method for cloning portions of the repeat regions of herpes simplex virus type 1.
J. Virol. Methods
46:111-116[Medline].
|
| 16.
|
Perng, G. C.,
H. Ghiasi,
S. M. Slanina,
A. B. Nesburn, and S. L. Wechsler.
1996.
High-dose ocular infection with a herpes simplex virus type 1 ICP34.5 deletion mutant produces no corneal disease or neurovirulence yet results in wild-type levels of spontaneous reactivation.
J. Virol.
70:2883-2893[Abstract].
|
| 17.
|
Perng, G. C.,
H. Ghiasi,
S. M. Slanina,
A. B. Nesburn, and S. L. Wechsler.
1996.
The spontaneous reactivation function of the herpes simplex virus type 1 LAT gene resides completely within the first 1.5 kilobases of the 8.3-kilobase primary transcript.
J. Virol.
70:976-984[Abstract].
|
| 18.
|
Perng, G. C.,
S. M. Slanina,
H. Ghiasi,
A. B. Nesburn, and S. L. Wechsler.
1996.
A 371-nucleotide region between the herpes simplex virus type 1 (HSV-1) LAT promoter and the 2-kilobase LAT is not essential for efficient spontaneous reactivation of latent HSV-1.
J. Virol.
70:2014-2018[Abstract].
|
| 19.
|
Perng, G. C.,
R. L. Thompson,
N. M. Sawtell,
W. E. Taylor,
S. M. Slanina,
H. Ghiasi,
R. Kaiwar,
A. B. Nesburn, and S. L. Wechsler.
1995.
An avirulent ICP34.5 deletion mutant of herpes simplex virus type 1 is capable of in vivo spontaneous reactivation.
J. Virol.
69:3033-3041[Abstract].
|
| 20.
|
Rock, D. L.,
A. B. Nesburn,
H. Ghiasi,
J. Ong,
T. L. Lewis,
J. R. Lokensgard, and S. L. Wechsler.
1987.
Detection of latency-related viral RNAs in trigeminal ganglia of rabbits latently infected with herpes simplex virus type 1.
J. Virol.
61:3820-3826[Abstract/Free Full Text].
|
| 21.
|
Sawtell, N. M., and R. L. Thompson.
1992.
Herpes simplex virus type 1 latency-associated transcription unit promotes anatomical site-dependent establishment and reactivation from latency.
J. Virol.
66:2157-2169[Abstract/Free Full Text].
|
| 22.
|
Schang, L. M.,
A. Hossain, and C. Jones.
1996.
The latency-related gene of bovine herpesvirus 1 encodes a product which inhibits cell cycle progression.
J. Virol.
70:3807-3814[Abstract].
|
| 23.
|
Trousdale, M. D.,
I. Steiner,
J. G. Spivack,
S. L. Deshmane,
S. M. Brown,
A. R. MacLean,
J. H. Subak-Sharpe, and N. W. Fraser.
1991.
In vivo and in vitro reactivation impairment of a herpes simplex virus type 1 latency-associated transcript variant in a rabbit eye model.
J. Virol.
65:6989-6993[Abstract/Free Full Text].
|
| 24.
|
Wagner, E. K.,
G. Devi-Rao,
L. T. Feldman,
A. T. Dobson,
Y. F. Zhang,
W. M. Flanagan, and J. G. Stevens.
1988.
Physical characterization of the herpes simplex virus latency-associated transcript in neurons.
J. Virol.
62:1194-1202[Abstract/Free Full Text].
|
| 25.
|
Wechsler, S. L.,
A. B. Nesburn,
R. Watson,
S. M. Slanina, and H. Ghiasi.
1988.
Fine mapping of the latency-related gene of herpes simplex virus type 1: alternative splicing produces distinct latency-related RNAs containing open reading frames.
J. Virol.
62:4051-4058[Abstract/Free Full Text].
|
| 26.
|
Zwaagstra, J. C.,
H. Ghiasi,
S. M. Slanina,
A. B. Nesburn,
S. C. Wheatley,
K. Lillycrop,
J. Wood,
D. S. Latchman,
K. Patel, and S. L. Wechsler.
1990.
Activity of herpes simplex virus type 1 latency-associated transcript (LAT) promoter in neuron-derived cells. Evidence for neuron specificity and for a large LAT transcript.
J. Virol.
64:5019-5028[Abstract/Free Full Text].
|
Journal of Virology, February 1999, p. 920-929, Vol. 73, No. 2
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Neumann, D. M., Bhattacharjee, P. S., Giordani, N. V., Bloom, D. C., Hill, J. M.
(2007). In Vivo Changes in the Patterns of Chromatin Structure Associated with the Latent Herpes Simplex Virus Type 1 Genome in Mouse Trigeminal Ganglia Can Be Detected at Early Times after Butyrate Treatment. J. Virol.
81: 13248-13253
[Abstract]
[Full Text]
-
Neumann, D. M., Bhattacharjee, P. S., Hill, J. M.
(2007). Sodium Butyrate: a Chemical Inducer of In Vivo Reactivation of Herpes Simplex Virus Type 1 in the Ocular Mouse Model. J. Virol.
81: 6106-6110
[Abstract]
[Full Text]
-
Cheung, A. K. L., Abendroth, A., Cunningham, A. L., Slobedman, B.
(2006). Viral gene expression during the establishment of human cytomegalovirus latent infection in myeloid progenitor cells. Blood
108: 3691-3699
[Abstract]
[Full Text]
-
Jones, C., Inman, M., Peng, W., Henderson, G., Doster, A., Perng, G.-C., Angeletti, A. K.
(2005). The Herpes Simplex Virus Type 1 Locus That Encodes the Latency-Associated Transcript Enhances the Frequency of Encephalitis in Male BALB/c Mice. J. Virol.
79: 14465-14469
[Abstract]
[Full Text]
-
Peng, W., Henderson, G., Inman, M., BenMohamed, L., Perng, G.-C., Wechsler, S. L., Jones, C.
(2005). The Locus Encompassing the Latency-Associated Transcript of Herpes Simplex Virus Type 1 Interferes with and Delays Interferon Expression in Productively Infected Neuroblastoma Cells and Trigeminal Ganglia of Acutely Infected Mice. J. Virol.
79: 6162-6171
[Abstract]
[Full Text]
-
Kubat, N. J., Amelio, A. L., Giordani, N. V., Bloom, D. C.
(2004). The Herpes Simplex Virus Type 1 Latency-Associated Transcript (LAT) Enhancer/rcr Is Hyperacetylated during Latency Independently of LAT Transcription. J. Virol.
78: 12508-12518
[Abstract]
[Full Text]
-
Mott, K. R., Osorio, N., Jin, L., Brick, D. J., Naito, J., Cooper, J., Henderson, G., Inman, M., Jones, C., Wechsler, S. L., Perng, G.-C.
(2003). The bovine herpesvirus-1 LR ORF2 is critical for this gene's ability to restore the high wild-type reactivation phenotype to a herpes simplex virus-1 LAT null mutant. J. Gen. Virol.
84: 2975-2985
[Abstract]
[Full Text]
-
Jin, L., Peng, W., Perng, G.-C., Brick, D. J., Nesburn, A. B., Jones, C., Wechsler, S. L.
(2003). Identification of Herpes Simplex Virus Type 1 Latency-Associated Transcript Sequences That both Inhibit Apoptosis and Enhance the Spontaneous Reactivation Phenotype. J. Virol.
77: 6556-6561
[Abstract]
[Full Text]
-
Lovato, L., Inman, M., Henderson, G., Doster, A., Jones, C.
(2003). Infection of Cattle with a Bovine Herpesvirus 1 Strain That Contains a Mutation in the Latency-Related Gene Leads to Increased Apoptosis in Trigeminal Ganglia during the Transition from Acute Infection to Latency. J. Virol.
77: 4848-4857
[Abstract]
[Full Text]
-
Jones, C.
(2003). Herpes Simplex Virus Type 1 and Bovine Herpesvirus 1 Latency. Clin. Microbiol. Rev.
16: 79-95
[Abstract]
[Full Text]
-
Perng, G.-C., Mott, K. R., Osorio, N., Yukht, A., Salina, S., Nguyen, Q.-H., Nesburn, A. B., Wechsler, S. L.
(2002). Herpes simplex virus type 1 mutants containing the KOS strain ICP34.5 gene in place of the McKrae ICP34.5 gene have McKrae-like spontaneous reactivation but non-McKrae-like virulence. J. Gen. Virol.
83: 2933-2942
[Abstract]
[Full Text]
-
Perng, G.-C., Maguen, B., Jin, L., Mott, K. R., Kurylo, J., BenMohamed, L., Yukht, A., Osorio, N., Nesburn, A. B., Henderson, G., Inman, M., Jones, C., Wechsler, S. L.
(2002). A Novel Herpes Simplex Virus Type 1 Transcript (AL-RNA) Antisense to the 5' End of the Latency-Associated Transcript Produces a Protein in Infected Rabbits. J. Virol.
76: 8003-8010
[Abstract]
[Full Text]
-
Inman, M., Lovato, L., Doster, A., Jones, C.
(2002). A Mutation in the Latency-Related Gene of Bovine Herpesvirus 1 Disrupts the Latency Reactivation Cycle in Calves. J. Virol.
76: 6771-6779
[Abstract]
[Full Text]
-
Perng, G.-C., Maguen, B., Jin, L., Mott, K. R., Osorio, N., Slanina, S. M., Yukht, A., Ghiasi, H., Nesburn, A. B., Inman, M., Henderson, G., Jones, C., Wechsler, S. L.
(2002). A Gene Capable of Blocking Apoptosis Can Substitute for the Herpes Simplex Virus Type 1 Latency-Associated Transcript Gene and Restore Wild-Type Reactivation Levels. J. Virol.
76: 1224-1235
[Abstract]
[Full Text]
-
Ahmed, M., Fraser, N. W.
(2001). Herpes Simplex Virus Type 1 2-Kilobase Latency-Associated Transcript Intron Associates with Ribosomal Proteins and Splicing Factors. J. Virol.
75: 12070-12080
[Abstract]
[Full Text]
-
Perng, G.-C., Esmaili, D., Slanina, S. M., Yukht, A., Ghiasi, H., Osorio, N., Mott, K. R., Maguen, B., Jin, L., Nesburn, A. B., Wechsler, S. L.
(2001). Three Herpes Simplex Virus Type 1 Latency-Associated Transcript Mutants with Distinct and Asymmetric Effects on Virulence in Mice Compared with Rabbits. J. Virol.
75: 9018-9028
[Abstract]
[Full Text]
-
Burton, E. A., Wechuck, J. B., Wendell, S. K., Goins, W. F., Fink, D. J., Glorioso, J. C.
(2001). Multiple Applications For Replication-Defective Herpes Simplex Virus Vectors. Stem Cells
19: 358-377
[Abstract]
[Full Text]
-
Arthur, J. L., Scarpini, C. G., Connor, V., Lachmann, R. H., Tolkovsky, A. M., Efstathiou, S.
(2001). Herpes Simplex Virus Type 1 Promoter Activity during Latency Establishment, Maintenance, and Reactivation in Primary Dorsal Root Neurons In Vitro. J. Virol.
75: 3885-3895
[Abstract]
[Full Text]
-
Colgin, M. A., Smith, R. L., Wilcox, C. L.
(2001). Inducible Cyclic AMP Early Repressor Produces Reactivation of Latent Herpes Simplex Virus Type 1 in Neurons In Vitro. J. Virol.
75: 2912-2920
[Abstract]
[Full Text]
-
Perng, G.-C., Slanina, S. M., Yukht, A., Ghiasi, H., Nesburn, A. B., Wechsler, S. L.
(2000). The Latency-Associated Transcript Gene Enhances Establishment of Herpes Simplex Virus Type 1 Latency in Rabbits. J. Virol.
74: 1885-1891
[Abstract]
[Full Text]
-
Lu, R., Misra, V.
(2000). Potential Role for Luman, the Cellular Homologue of Herpes Simplex Virus VP16 (alpha Gene trans-Inducing Factor), in Herpesvirus Latency. J. Virol.
74: 934-943
[Abstract]
[Full Text]